AC Immune (ACIU) Net Equity Issued and Repurchased (2015 - 2025)
AC Immune's Net Equity Issued and Repurchased was -$1,251 in the quarter ended Dec 31, 2025.
Analysis
AC Immune (ACIU) Net Equity Issued and Repurchased (2015 - 2025) Analysis & Trends
For the year ended Dec 31, 2025, Net Equity Issued and Repurchased at AC Immune came in at $7,237, down 9.1% from the prior year.
- Net Equity Issued and Repurchased shows a five-year compound annual growth rate of -45.6% (years ended Dec 2020 to Dec 2025).
- In earlier years, Net Equity Issued and Repurchased was $7,957 in the year ended Dec 31, 2024 (-100.0%), $45.71 million in the year ended Dec 31, 2023, $7,338 in the year ended Dec 31, 2022 (-99.9%) and $5.03 million in the year ended Dec 31, 2021.
- Quarterly Net Equity Issued and Repurchased has moved between -$13,273 (the quarter ended Mar 31, 2021) and $46.22 million (the quarter ended Dec 31, 2023) over five years.
- Per Business Quant data, ACIU's Net Equity Issued and Repurchased in the three quarters before the quarter ended Dec 31, 2025 was $5,000 (quarter ended Sep 30, 2025), $9,663 (quarter ended Jun 30, 2025) and -$5,561 (quarter ended Mar 31, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 43.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 6.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 9.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 47.70 Mn |
| 10 | AC Immune | 266.56 Mn | 266.56 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -1,251.17 |
| Sep 30, 2025 | 5,000.44 |
| Jun 30, 2025 | 9,663.12 |
| Mar 31, 2025 | -5,561.25 |
| Sep 30, 2024 | 1,154.21 |
| Jun 30, 2024 | 4,423.17 |
| Mar 31, 2024 | 2,291.36 |
| Dec 31, 2023 | 46.22 Mn |
| Sep 30, 2023 | 82,647.14 |
| Jun 30, 2023 | -7,785.23 |
| Mar 31, 2023 | -6,486.98 |
| Sep 30, 2022 | 1,035.46 |
| Jun 30, 2022 | 5,191.47 |
| Mar 31, 2022 | 1,082.81 |
| Dec 31, 2021 | 4.70 Mn |
| Sep 30, 2021 | 204,756.27 |
| Jun 30, 2021 | 93,215.00 |
| Mar 31, 2021 | -13,272.71 |
| Sep 30, 2020 | 158,609.36 |
| Jun 30, 2020 | 1,037.81 |
API Access
AC Immune Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=ACIU&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "ACIU", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=ACIU&period=max&api_key=YOUR_API_KEY");
const data = await res.json();